Rheumatologic adverse events in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
Rheumatologic adverse events in patients with metastatic renal cell carcinoma treated with immune...
Read More
Kidney Cancer Journal
Results of lymph node dissection for locally advanced and metastatic renal cell carcinoma
Results of lymph node dissection for locally advanced and metastatic renal cell carcinoma Abstract...
Read More
Quality-adjusted survival of nivolumab vs. everolimus in patients with previously treated advanced renal cell carcinoma (aRCC): a Q-TWiST analysis
Quality-adjusted survival of nivolumab vs. everolimus in patients with previously treated advanced...
Read More
PT2977, a Novel HIF-2a Antagonist, Affords Potent Anti-Tumor Activity and Remodels the Immunosuppressive Tumor Microenvironment in Clear Cell Renal Cell Cancer
PT2977, a Novel HIF-2a Antagonist, Affords Potent Anti-Tumor Activity and Remodels the...
Read More
Productivity, Satisfaction, and HealthRelated Quality of Life in Advanced Renal Cell Carcinoma Patients Receiving 2 or More Lines of Treatment: Results from a United Kingdom (UK) chart review
Productivity, Satisfaction, and HealthRelated Quality of Life in Advanced Renal Cell Carcinoma...
Read MoreExercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan